EDGAR Filing Documents for 0000885590-13-000014

Form 10-K - Annual report [Section 13 and 15(d), not S-K Item 405]:

SEC Accession No. 0000885590-13-000014

Filing Date

2013-02-28

Accepted

2013-02-28 16:00:27

Documents

Period of Report

2012-12-31

Document Format Files

Seq	Description	Document	Type	Size
1	10-K	valeant2012form10-k.htm	10-K	4816250
2	EXHIBIT 2.9	exhibit29.htm	EX-2.9	490563
3	EXHIBIT 10.18	exhibit1018.htm	EX-10.18	61676
4	EXHIBIT 10.19	exhibit1019.htm	EX-10.19	78672
5	EXHIBIT 10.25	exhibit1025.htm	EX-10.25	1655027
6	EXHIBIT 10.26	exhibit1026.htm	EX-10.26	1759090
7	EXHIBIT 10.31	exhibit1031.htm	EX-10..31	146001
8	EXHIBIT 21.1	exhibit211.htm	EX-21.1	210240
9	EXHIBIT 23.1	exhibit231.htm	EX-23.1	2875
10	EXHIBIT 23.2	exhibit232.htm	EX-23.2	4638
11	EXHIBIT 23.3	exhibit233.htm	EX-23.3	9204
12	EXHIBIT 31.1	exhibit311.htm	EX-31.1	14827
13	EXHIBIT 31.2	exhibit312.htm	EX-31.2	14595
14	EXHIBIT 32.1	exhibit321.htm	EX-32.1	8789
15	EXHIBIT 32.2	exhibit322.htm	EX-32.2	8717
22		newimagegraph.jpg	GRAPHIC	85643
	Complete submission text file	0000885590-13-000014.txt		42325143

Data Files

Seq	Description	Document	Type	Size
16	EXHIBIT 101 INS	vrx-20121231.xml	EX-101.INS	6291738
17	EXHIBIT 101 SCH	vrx-20121231.xsd	EX-101.SCH	244368
18	EXHIBIT 101 CAL	vrx-20121231_cal.xml	EX-101.CAL	196515
19	EXHIBIT 101 LAB	vrx-20121231_lab.xml	EX-101.LAB	3499248
20	EXHIBIT 101 PRE	vrx-20121231_pre.xml	EX-101.PRE	1843462
21	EXHIBIT 101 DEF	vrx-20121231_def.xml	EX-101.DEF	1377757

Mailing Address 4787 LEVY STREET MONTREAL QUEBEC A8 H4R 2P9

Business Address 4787 LEVY STREET MONTREAL QUEBEC A8 H4R 2P9 514-744-6792

Valeant Pharmaceuticals International, Inc. (Filer) CIK: 0000885590 (see all company filings)